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Bacillus and Pseudomonas Genera as a Potential Source for 
Novel Antibiotics
Cory Jayne and Dr. Lori Scott, Augustana College
INTRODUCTION
The need for new antibiotics is an ever-growing issue in the 
medical field due to a multitude of issues, most notably the 
over-prescription of antibiotics and the non-cooperation of 
patients in following the advised prescription time period.1 This 
has led to multiple drugs becoming resistant to the various 
drugs used to treat them. The ESKAPE bacteria are a group of 
six bacteria that are considered in critical or high need of 
finding new antibiotics (Figure 1). The six bacteria are 
Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacter spp. Through collaboration with 
the Tiny Earth Project Initiative, a worldwide database focused 
on finding novel antibiotics for the treatment of the ESKAPE 
strains, we hope to discover antibiotics through bacteria found 
in soil.2
Fig 1. The ESKAPE strains are becoming more resistant to 
the antibiotics used to treat them.5 The graph shows common 
antibiotics and what percentage of just one strain, Enterococcus 
faecium, is resistant to them. 
With the rise of methicillin-resistant Staphylococcus aureus
(MRSA), among various other bacteria, hospital-acquired 
infections (HAI) are becoming a more significant issue.1
Staphylococcus aureus and different other strains of the 
Staphylococcus genus are commonly found in surgical site 
infections (SSI).3 A study done by Pal et al. showed that 20.8% 
of patients in a rural hospital in India obtained either a primary 
or secondary SSI after their procedure. A primary SSI is an 
infection typically occurring within seven days of the 
operation, generally while still in the hospital. A secondary SSI 
is an infection acquired after leaving the hospital. Of the 
patients who acquired an SSI post-surgery, 64.8% had the 
bacteria Staphylococcus in the infection 69.9% of which was 
MRSA, or methicillin-sensitive Staphylococcus aureus
(MSSA). The discovery of new antibiotics to treat 
Staphylococcus aureus is in dire need. Similarly, the genus 
Bacillus can cause a wide range of issues, including infections, 
anthrax, and endocarditis.4 
Through the use of the safe test strains Staphylococcus 
epidermidis and Bacillus subtilis, we can use a variety of 
molecular and biochemical procedures to find and isolate new 
antibiotic-producing bacteria. These strains, which are 
evolutionarily similar to the ESKAPE strains, allow for the safe 
testing and potential discovery of novel antibiotics against 
Staphylococcus aureus and Bacillus anthracis. Identification 
and isolation of antibiotic-producing bacteria will be reported 
back into the global network of the Tiny Earth Project 
Initiative.
METHODS
In collaboration with the Tiny Earth Project Initiative we were 
able to use many of their procedures described.2 Unless otherwise 
noted, all of the procedures were followed exactly.
• Collect soil sample 
• Serial Dilution of soil samples and isolation of microbes
• Media and selective media for isolation (10% TSA, LB, PDA)
• Formation of master plates
• Testing microbial isolates for the production of secondary 
metabolites with antibiotics (Staphylococcus epidermidis, 
Bacillus subtilis, and Erwinia carotovora)
• Formation of streak plates to allow for further testing
• Differential media for potential identification of isolates 
(MacConkey, Simmons’ citrate, MSA, TSI slants, and blood 
agar)
• PCR of any antibiotic producing microbes (16S rRNA gene 
primers are 27F and 1492R)
• Gel electrophoresis of PCR products (1% agarose gel)
• Sequencing of the DNA of 16S rRNA gene (Iowa Institute of 
Human Genetics, University of Iowa)
DISCUSSION
We were able to successful identify the genus of isolates CJ-1-
TSA and CJ-4-PDA as Pseudomonas and Bacillus. For these two 
isolates we were able to conclude that they have the potential to 
be broad spectrum antibiotics against both Staphylococcus 
epidermidis and Bacillus subtilis.
Future directions of this project would include the isolation of the 
actual secondary metabolite. This would involve organic and 
biochemical separation techniques. Further directions would 
include full genome sequencing through the Tiny Earth Project 
Initiative and the potential identification of the structure of the 
secondary metabolite. 
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RESULTS
Figure 2. Evidence of antibiotic producing isolates present 
against both of my Gram-positive strains, Staphylococcus 
epidermidis and Bacillus subtilis. Halos were present in the first 
and third columns, Staphylococcus epidermidis and Bacillus 
subtilis respectively. The middle column was a Gram-negative 
bacteria, Erwinia carotovora. The plates were grown on LB at 
28oC for 24 hours.
Figure 3. Successful amplification of the 16S rRNA gene from 
PCR. We were able to amplify the DNA from the bacteria in 
lanes 3,5,7, and 9. In these lanes were isolates CJ-1-TSA, CJ-2-
TSA, CJ-4-PDA, and CJ-5-PDA, respectively. With the primers 
we chose, the DNA bands we expected, and produced, were 
around 1.4Kb. The PCR product was run for 25 minutes on a 1% 
agarose gel. 
RESULTS (CONTINUED)
Figure 4. 16S rRNA gene sequence data, showing that isolate 
CJ-1-TSA, and CJ-4-PDA are from the genus Pseudomonas
and Bacillus respectively.6 The description section lists the 
possible strains that our unknown isolates were. Query cover is 
the percentage of the actual gene that our sequenced data matches 
up with, in this case we did not amplify the entire gene, but 
instead about 98%. The E value is the likelihood that we just 
randomly obtained these strains. Finally, the percent identity is 
the percent of nucleotides from our isolates that line up exactly 
with the known strains in the description.  
